Specific Inhibition of DNMT3A/ISGF3γ Interaction Increases the Temozolomide Efficiency to Reduce Tumor Growth

Abstract : DNA methylation is a fundamental feature of genomes and is a candidate for pharmacological manipulation that might have important therapeutic advantage. Thus, DNA methyltransferases (DNMTs) appear to be ideal targets for drug intervention. By focusing on interactions existing between DNMT3A and DNMT3A-binding protein (D3A-BP), our work identifies the DNMT3A/ISGF3γ interaction such as a biomarker whose the presence level is associated with a poor survival prognosis and with a poor prognosis of response to the conventional chemotherapeutic treatment of glioblastoma multiforme (radiation plus temozolomide). Our data also demonstrates that the disruption of DNMT3A/ISGF3γ interactions increases the efficiency of chemotherapeutic treatment on established tumors in mice. Thus, our data opens a promising and innovative alternative to the development of specific DNMT inhibitors.
Type de document :
Article dans une revue
Theranostics, Ivyspring International Publisher, 2016, 6, pp.1988 - 1999. 〈10.7150/thno.9150〉
Liste complète des métadonnées

Littérature citée [35 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01414173
Contributeur : Elizabeth Bernardo <>
Soumis le : lundi 12 décembre 2016 - 10:35:43
Dernière modification le : jeudi 5 avril 2018 - 10:36:33
Document(s) archivé(s) le : mardi 28 mars 2017 - 00:54:28

Fichier

2016Art3Eq9.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Mathilde Cheray, Romain Pacaud, Arulraj Nadaradjane, Lisa Oliver, François Vallette, et al.. Specific Inhibition of DNMT3A/ISGF3γ Interaction Increases the Temozolomide Efficiency to Reduce Tumor Growth. Theranostics, Ivyspring International Publisher, 2016, 6, pp.1988 - 1999. 〈10.7150/thno.9150〉. 〈inserm-01414173〉

Partager

Métriques

Consultations de la notice

166

Téléchargements de fichiers

78